Medigus Expands Commercial Availability of MUSE to Spain

Medical Device Investing

Medigus announced a distribution agreement with Izasa Hospital, distributor of medical products in the hospital sector in Spain.

Medigus (NASDAQ:MDGS) announced a distribution agreement with Izasa Hospital, distributor of medical products in the hospital sector in Spain.
As quoted in the press release:

The five year commercialization agreement took effect July 1, 2017; Izasa Hospital, S.L.U. will be required to purchase a minimum of EUR 1.4 million of Medigus Ultrasonic Surgical Endostapler (MUSE™) equipment over the course of the agreement.
“About twenty-six percent of Europe’s population experience reflux on a weekly basis1; we will now be able to better address this prolific issue with the introduction of MUSE in Spain,” said Mr. Alfonso Garcia, General Manager of Izasa Hospital, S.L.U. “MUSE addresses an unmet need in long-term GERD care, and we feel that our customers and their patients will benefit from the use of this innovative treatment option.”
“The MUSE system offers a minimally invasive solution for gastroesophageal reflux disease (GERD), and we are excited to expand availability to Spain, an important development market for our organization,” said Chris Rowland, Chief Executive Officer of Medigus. “We are looking forward to collaborating with Izasa Hospital to help provide patients and the healthcare community with innovative and advanced technologies that enhance patient care and outcomes.”

Click here to read the full press release.

Source: www.marketwired.com

The Conversation (0)
×